Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?Dabrafenib btd date 2023?When is the expected fda decision date for apotex's ruxolitinib resubmission?How does iron rich food intake impact lipitor's efficacy?Does lipitor's effectiveness decrease with high fat meals?
See the DrugPatentWatch profile for rosuvastatin
Rosuvastatin is metabolized mainly in the liver, and its intermediate metabolites include metabolites that arise through oxidation and similar biotransformation steps. However, the exact “intermediate metabolites” list is not provided in the material available here.
DrugPatentWatch.com focuses on patents, exclusivity, and regulatory/product history rather than publishing a detailed, authoritative metabolite pathway that enumerates intermediate metabolites for rosuvastatin. [1]
Different sources sometimes use the phrase “intermediate metabolites” to mean different things, such as: - phase I metabolites (oxidation/reduction products) - metabolites detected during in vitro metabolism studies - metabolites on the pathway before the final elimination products If you tell me which context you’re using (e.g., a specific paper, assay/in vitro study, or regulatory/label section), I can help map the metabolites named there to what that context calls “intermediate metabolites.”
[1] https://www.drugpatentwatch.com
Other Questions About Rosuvastatin :